RESUMEN
BACKGROUND: COVID-19 has profoundly affected the work of mental health professionals with many transitioning to telehealth to comply with public health measures. This large international study examined the impact of the pandemic on mental health clinicians' telehealth use. METHODS: This survey study was conducted with mental health professionals, primarily psychiatrists and psychologists, registered with WHO's Global Clinical Practice Network (GCPN). 1206 clinicians from 100 countries completed the telehealth section of the online survey in one of six languages between June 4 and July 7, 2020. Participants were asked about their use, training (i.e., aspects of telehealth addressed), perceptions, and concerns. OUTCOMES: Since the pandemic onset, 1092 (90.5%) clinicians reported to have started or increased their telehealth services. Telephone and videoconferencing were the most common modalities. 592 (49.1%) participants indicated that they had not received any training. Clinicians with no training or training that only addressed a single aspect of telehealth practice were more likely to perceive their services as somewhat ineffective than those with training that addressed two or more aspects. Most clinicians indicated positive perceptions of effectiveness and patient satisfaction. Quality of care compared to in-person services and technical issues were the most common concerns. Findings varied by WHO region, country income level, and profession. INTERPRETATION: Findings suggest a global practice change with providers perceiving telehealth as a viable option for mental health care. Increasing local training opportunities and efforts to address clinical and technological concerns is important for meeting ongoing demands.
Asunto(s)
COVID-19 , Telemedicina , Personal de Salud , Humanos , Salud Mental , PandemiasRESUMEN
This pilot study examined violence risk assessment among a sample of young adults receiving treatment for early psychosis. In this study, thirty participants were assessed for violence risk at baseline. Participants completed follow-up assessments at 3, 6, 9 and 12 months to ascertain prevalence of violent behavior. Individuals were on average 24.1 years old (SD = 3.3 years) and predominantly male (n = 24, 80%). In this sample, six people (20%) reported engaging in violence during the study period. Individuals who engaged in violence had higher levels of negative urgency (t(28) = 2.21, p = 0.035) This study sought to establish the feasibility, acceptability, and clinical utility of violence risk assessment for clients in treatment for early psychosis. Overall, this study found that most individuals with early psychosis in this study (who are in treatment) were not at risk of violence. Findings suggest that violent behavior among young adults with early psychosis is associated with increased negative urgency.
Asunto(s)
Trastornos Psicóticos , Adulto , Estudios de Factibilidad , Femenino , Humanos , Masculino , Proyectos Piloto , Trastornos Psicóticos/epidemiología , Trastornos Psicóticos/terapia , Medición de Riesgo , Violencia , Adulto JovenRESUMEN
Accounts of killings of civilians by police in the United States (U.S.) have attracted considerable public attention. In this study, using all civilian deaths (Nâ¯=â¯1099) in the U.S. in 2015, compiled independently by The Washington Post and The Guardian newspapers, we identified characteristics of each interaction between the police and the deceased, such as whether the decedent was armed. We expanded the database to include systemic factors possibly related to these deaths, and examined death rates by demographics, presence of mental illness, and state-level predictors. Twenty-three percent (251 of 1099) of individuals killed during interactions with police in 2015 displayed signs of a mental illness. Race (African-American [RRâ¯=â¯2.57] compared to non-Hispanic Whites [95% CI 2.08-3.18]) and presence of mental illness (RRâ¯=â¯7.16 compared to no mental illness, 95% CI 6.21-8.25) were strongly associated with such fatalities. Individuals with mental illness were more likely to be armed with a knife (ORâ¯=â¯3.1, 95% CI 2.1-4.6), and were more likely to have been killed at home (ORâ¯=â¯2.8, 95% CI 1.9-4.0). The death rates for persons with evidence of mental illness during interactions with police are high. Our finding that many persons with mental illness were killed at home and were not brandishing a firearm suggests that more effective de-escalation methods might reduce the incidence of fatal outcomes.
Asunto(s)
Homicidio , Aplicación de la Ley , Personas con Discapacidades Mentales , Adolescente , Adulto , Bases de Datos Factuales , Femenino , Homicidio/estadística & datos numéricos , Humanos , Masculino , Estados Unidos/epidemiología , Adulto JovenRESUMEN
Sequential multiple assignment randomized trials (SMARTs) are increasingly being used to inform clinical and intervention science. In a SMART, each patient is repeatedly randomized over time. Each randomization occurs at a critical decision point in the treatment course. These critical decision points often correspond to milestones in the disease process or other changes in a patient's health status. Thus, the timing and number of randomizations may vary across patients and depend on evolving patient-specific information. This presents unique challenges when analyzing data from a SMART in the presence of missing data. This paper presents the first comprehensive discussion of missing data issues typical of SMART studies: we describe five specific challenges and propose a flexible imputation strategy to facilitate valid statistical estimation and inference using incomplete data from a SMART. To illustrate these contributions, we consider data from the Clinical Antipsychotic Trial of Intervention and Effectiveness, one of the most well-known SMARTs to date.
Asunto(s)
Interpretación Estadística de Datos , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Antipsicóticos/uso terapéutico , Toma de Decisiones , Humanos , Estudios Longitudinales , Análisis de Regresión , Esquizofrenia/tratamiento farmacológicoRESUMEN
UNLABELLED: One important risk factor for cardiovascular disease is the metabolic syndrome (MS), yet limited data exist on its prevalence in US patients with schizophrenia. METHODS: Using baseline data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial, assessment of MS prevalence was performed based on National Cholesterol Education Program (NCEP) criteria, and also using a fasting glucose threshold of 100 mg/dl (AHA). Subjects with sufficient anthropometric data, data on use of antihypertensives, hypoglycemic medications or insulin, and fasting glucose and lipid values >8 h from last meal were included in the analysis. Comparative analyses were performed using a randomly selected sample from NHANES III matched 1:1 on the basis of age, gender and race/ethnicity. RESULTS: Of 1460 CATIE baseline subjects, 689 met analysis criteria. MS prevalence was 40.9% and 42.7%, respectively using the NCEP and AHA derived criteria. In females it was 51.6% and 54.2% using the NCEP and AHA criteria, compared to 36.0% (p = .0002) and 36.6% (p = .0003), respectively for males. 73.4% of all females (including nonfasting subjects) met the waist circumference criterion compared to 36.6% of males. In a logistic regression model with age, race and ethnicity as covariates, CATIE males were 138% more likely to have MS than the NHANES matched sample, and CATIE females 251% more likely than their NHANES counterparts. Even when controlling for differences in body mass index, CATIE males were still 85% more likely to have MS than the NHANES male sample, and CATIE females 137% more likely to have MS than females in NHANES. CONCLUSIONS: The metabolic syndrome is highly prevalent in US schizophrenia patients and represents an enormous source of cardiovascular risk, especially for women. Clinical attention must be given to monitoring for this syndrome, and minimizing metabolic risks associated with antipsychotic treatment.